Patent · US Active

Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA

US8927515B2 · kind B2 · utility

5Cited by

1References

42Claims

0Family size

Assignee

Dicerna Pharmaceuticals, Inc. · US

Inventors

Bob D. Brown · Littleton, US
Henryk T. Dudek · Wellesley, US

Key dates

Filing date	Dec 21, 2012
Grant date	Jan 6, 2015
Priority date	—
Expiry date	Mar 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to compounds, compositions, and methods useful for reducing AR target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.